Navigation Links
Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
Date:2/7/2013

SUNNYVALE, Calif., Feb. 7, 2013 /PRNewswire/ -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC) today announced that it will report financial results and recent developments for its three and six months ended December 31, 2012  after the NASDAQ Market closes on Thursday, February 14, 2013.  The Company will conduct a conference call and audio webcast at 4:30 p.m ET on the same day. As previously announced, the Company changed its fiscal year end from June 30 to December 31, effective December 31, 2012. As a result, the six months ended December 31, 2012 represent a transition period, with the next fiscal year covering the period from January 1, 2013 through December 31, 2013.

Conference call and webcast details:

Date: February 14, 2013
Time: 4:30 PM ET
Listen via Internet: http://ir.pharmacyclics.com/events.cfm
Toll-free: (877)-407-0778
International: (201)-689-8565

Replay Number (Toll Free): (877)-660-6853
Replay Number (International): (201)-612-7415
Conference ID #: 409002

A webcast replay will be available on the Pharmacyclics website for 30 days.

About Pharmacyclics
Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medical healthcare needs; and to identify promising product candidates based on scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when
'/>"/>

SOURCE PHARMACYCLICS/ ACCOUNTS PAYABLE
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
2. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
3. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
4. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
5. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
6. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
7. Misonix Announces New Distribution Agreement For Panama
8. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
9. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
10. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
11. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... March 2, 2015 Valencia Technologies Corporation (" ... patient with its radically small device for the treatment ... results in this randomized, double-blinded, controlled trial are compelling ... confidence that it will succeed in a large U.S. ... clinical results, Valencia has successfully ...
(Date:3/2/2015)... Following announcements from both Novartis and ... Inc. (NASDAQ:  ARRY) today announced the completion of ... Novartis.  Along with global ownership of both assets, ... million from Novartis. Ron Squarer, Chief ... the Novartis-GSK transaction, Array now owns both binimetinib ...
(Date:3/2/2015)... , March 2, 2015  Galmed Pharmaceuticals Ltd. ... company focused on the development and commercialization of a ... and cholesterol gallstones, today announced that Josh Blacher ... at the 27th Annual ROTH conference in ... 2015 at 2:30 PM Pacific Standard Time. A live ...
Breaking Medicine Technology:Valencia Technologies Implants its 48th Patient, Continues Equity Crowdfunding 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 3Array Announces Completion Of Binimetinib And Encorafenib Transactions 4Array Announces Completion Of Binimetinib And Encorafenib Transactions 5Galmed Pharmaceuticals to Present at the 27th Annual ROTH Conference 2
(Date:3/2/2015)... Dinner preparation and meal planning have ... of DinnerDork , a company that specializes ... thousands of busy customers. The company recently responded ... offer a total of 6 diverse meal plan ... recipes and comfort foods; Paleo Palette, which caters ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Regulatory ... focused on quality, regulatory and technical consulting, announces ... Chief Operating Officer. , Before joining RCA, ... leading R&D teams in all aspects of developing ... positions at Covidien (Medtronic), Regulatory Compliance Associates Inc., ...
(Date:3/2/2015)... March 02, 2015 What are the ... physicians request references? When are interviews scheduled, how can ... opportunities?, Both training and practicing physicians who are looking ... questions and more at the PracticeLink Physician Career Advancement ... drop-in Job Fair is from 5:30 to 8:30 p.m. ...
(Date:3/2/2015)... ProvidaStaff has announced today that ... division to EDU Healthcare to reflect better ... systems and students nationwide. , “ProvidaStaff has always been ... the country,” said Angela M. Lewis, President of ProvidaStaff. ... and the introduction of EDU Healthcare better aligns our ...
(Date:3/2/2015)... Secura Consultants announced today the ... Protective Insurance Group of Birmingham, AL (First Protective). ... affiliated advisors to access the enhanced disability income ... delivers. , Secura Consultants, based in ... design and implementation of insured income protection programs. ...
Breaking Medicine News(10 mins):Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 3Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 3Health News:Secura Consultants and First Protective Insurance Group Announce Strategic Relationship 2
... ... Rules Technology without Spending a Dime , ... Redwood City, CA (PRWEB) October 19, 2009 -- Corticon Technologies, ... another breakthrough in the Business Rules industry with the immediate availability of Corticon RulesWorld™. ...
... the U.S. Department of Justice issued formal guidelines for federal ... of marijuana for medical purposes. A memo from Deputy Attorney ... new position of the department. , The memo provided in ... priorities should not focus federal resources in your ...
... 19 Solomon Nathaniel of Sterling Heights, Mich., pleaded ... participating in a conspiracy to defraud the Medicare program, ... Criminal Division, U.S. Attorney Terrence Berg of the Eastern ... of the Department of Health & Human Services (HHS). ...
... blood flow is blocked protects tissue, animal study finds, ... research, scientists have shown in animal studies that providing ... damage. , But it,s not a simple matter. Success ... on when 100 percent oxygen is given. , ...
... when compared to kids without disorder , MONDAY, Oct. ... differences in blood mercury levels between children who are ... spectrum disorders. , The findings, appearing online Oct. 19 ... quell some of the debate surrounding mercury and autism. ...
... D.C., October 19, 2009 With chronic diseases on ... to improve care and outcomes for these often complex ... announced a new initiative funded with a grant from ... allow pediatricians across the country to pilot a series ...
Cached Medicine News:Health News:Corticon Launches RuleWorld Community and Free Business Rules Software 2Health News:Corticon Launches RuleWorld Community and Free Business Rules Software 3Health News:Corticon Launches RuleWorld Community and Free Business Rules Software 4Health News:Detroit-Area Physical Therapist Pleads Guilty in Medicare Fraud Scheme 2Health News:Timing of Oxygen After a Stroke May Matter 2Health News:Mercury Levels Not Abnormal in Autistic Children 2Health News:Mercury Levels Not Abnormal in Autistic Children 3Health News:Pediatricians put proven treatment strategies to work against childhood asthma 2
... has been providing accurate, reliable PT/INR results where ... care. , The CoaguChek System is the instrument ... monitoring on Coumadin (warfarin sodium) therapy. The CoaguChek ... from a fingerstick drop (10ul) of whole blood ...
The QuickScreen Pro Multi Drug Screening Test is a rapid, self-timing, qualitative immunoassay for,the detection of drugs of abuse in urine....
... ADC drugs of abuse tests are highly accurate ... SAMHSA recommended cut-off as confirmed by GC/MS testing. ... more specific alternative method (such as GC/MS) must ... result. Professional judgment should be applied to any ...
The Osteomark NTx Point of Care (POC)device allows physicians to monitor their patients response to anti-resorptive drugs as early as 3-6 months from starting treatment. Osteomark NTx shows you and y...
Medicine Products: